| __timestamp | Evotec SE | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 89496000 | 1777824000000 |
| Thursday, January 1, 2015 | 127677000 | 1807378000000 |
| Friday, January 1, 2016 | 164507000 | 1732051000000 |
| Sunday, January 1, 2017 | 257630000 | 1770531000000 |
| Monday, January 1, 2018 | 375405000 | 2097224000000 |
| Tuesday, January 1, 2019 | 446437000 | 3291188000000 |
| Wednesday, January 1, 2020 | 500924000 | 3197812000000 |
| Friday, January 1, 2021 | 618034000 | 3569006000000 |
| Saturday, January 1, 2022 | 751448000 | 4027478000000 |
| Sunday, January 1, 2023 | 781426000 | 4263762000000 |
| Monday, January 1, 2024 | 4263762000000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, Takeda Pharmaceutical Company Limited and Evotec SE stand as titans, each with a unique trajectory. Over the past decade, Takeda has consistently demonstrated its dominance, with revenues soaring by approximately 140% from 2014 to 2023. This growth underscores Takeda's strategic expansions and robust market presence.
Conversely, Evotec SE, while smaller in scale, has shown remarkable agility. Its revenue has increased by nearly 800% over the same period, reflecting its innovative approach and niche market strategies. Despite the disparity in absolute figures, Evotec's growth rate is a testament to its dynamic business model.
As we look to the future, the absence of Evotec's 2024 data leaves room for speculation. Will Evotec continue its upward trajectory, or will Takeda further consolidate its lead? The coming years will undoubtedly reveal more about these pharmaceutical powerhouses.
Takeda Pharmaceutical Company Limited and BioMarin Pharmaceutical Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Takeda Pharmaceutical Company Limited vs Pharming Group N.V.
Takeda Pharmaceutical Company Limited vs Lantheus Holdings, Inc.: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited vs Dynavax Technologies Corporation: Annual Revenue Growth Compared
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Evotec SE
Takeda Pharmaceutical Company Limited and Evotec SE: SG&A Spending Patterns Compared
BeiGene, Ltd. or Evotec SE: Who Leads in Yearly Revenue?
Revenue Showdown: Lantheus Holdings, Inc. vs Evotec SE
Annual Revenue Comparison: Bausch Health Companies Inc. vs Evotec SE